Our People

Bridget Barber

Associate Professor | Team Head

Clinical Malaria

bridget.barber@qimrberghofer.edu.au

 

CAREER HISTORY

Associate Professor Bridget Barber is Team Head of the Clinical Malaria group at QIMR Berghofer and an Infectious Diseases Physician at Royal Brisbane and Women’s Hospital. She completed her PhD in 2014 at Menzies School of Health Research with Professor Nicholas Anstey. For her PhD, she established a clinical research site in Sabah, Malaysia and led a large tertiary-hospital based prospective study of the epidemiology, clinical and pathophysiological features of knowlesi, falciparum and vivax malaria.  Following her PhD she was awarded an NHMRC Early Career Fellowship to continue her malaria research in Malaysia.

Her outputs from her studies in Malaysia have made a major contribution to the current understanding of knowlesi malaria. This has included the first descriptions of the use of intravenous artesunate for the treatment of knowlesi malaria; the first systematic evaluations of microscopy and rapid diagnostic tests for the diagnosis of P. knowlesi; the first descriptions of knowlesi malaria in children and in pregnancy; and first detailed reports of pathogenesis of knowlesi malaria.

She has also led studies demonstrating the increase in knowlesi malaria in Sabah as the human malaria species approach elimination and has implemented a state-wide malaria surveillance study in Sabah. She was involved in randomised controlled trials in knowlesi and vivax malaria and most recently led a randomised controlled trial of paracetamol for the attenuation of acute kidney injury in knowlesi malaria. Bridget joined Professor James McCarthy’s group at QIMR Berghofer in 2018, and now leads the Clinical Malaria group in conducting malaria volunteer infection studies. 

 

CURRENT APPOINTMENTS

2019-current: Team Head, Clinical Malaria, QIMR Berghofer

2019-current: Associate Professor, Menzies School of Health Research

2019-current: Infectious Diseases Physician, Royal Brisbane and Women’s Hospital

 

PREVIOUS APPOINTMENTS

2018-2019: Research Fellow, QIMR Berghofer Medical Research Institute

2016-2019: Infectious Diseases Physician, Ipswich Hospital

2013-2018: Senior Research Fellow, Menzies School of Health Research, Darwin

2012-2013: Infectious Diseases Physician, Epworth Eastern, Victoria

2010-2013: PhD Student, Menzies School of Health Research, Darwin

 

ORCID NUMBER

https://orcid.org/0000-0003-1066-7960

 

CURRENT AREA OF RESEARCH

Associate Professor Barber heads the Clinical Malaria Group, which focuses on using the induced blood stage malaria (IBSM) model to evaluate antimalarials in healthy human volunteers and to improve understanding of parasite biology and of host response to disease. 

In addition, she continues to work with collaborators at Menzies School of Health Research and in Sabah, Malaysia, to study the emergence of zoonotic knowlesi malaria as Malaysia approaches elimination of the human-only malaria species. Bridget utilises samples from both volunteer infection studies at QIMR Berghofer and from clinical studies in Malaysia to investigate comparative pathophysiological mechanisms of disease in severe falciparum, vivax and knowlesi malaria, with the aim of identifying targets for adjunctive treatment.

 

RESEARCH HIGHLIGHTS

2019: completion of an RCT evaluating paracetamol for the attenuation of acute kidney injury in knowlesi malaria

2013-2020: Senior author on a series of papers reporting the ongoing increase in knowlesi malaria in Sabah, Malaysia, as the human-only malaria species are brought under control

2013: completion of first systematic evaluation of microscopy and rapid diagnostic tests for the diagnosis of knowlesi malaria. Highlighted the importance of PCR for diagnosing P. knowlesi malaria

2013: completion of first prospective study to compare in the same population the clinical and biochemical features of knowlesi, vivax and falciparum malaria.  Demonstrated that P. knowlesi was at least as likely as P. falciparum to cause severe disease, and that parasitemia and older age were major risk factors. Also demonstrated that intravenous artesunate was highly effective for the treatment of severe knowlesi malaria

 

PROFESSIONAL MEMBERSHIPS

2020                     

  • Member, Drug Treatment and Chemoprophylaxis Panel, National COVID-19 Clinical Evidence Taskforce

2018

  • Fellow, NHMRC Australian Centre for Research Excellence in Malaria Elimination

2016-2019

  • Associate Member/Mentee, Australian Academy of Health and Medical Sciences

2012-current                     

  • Member, American Society of Tropical Medicine and Hygiene

2010-current                     

  • Fellow, Royal Australasian College of Physicians
  • Member, Infectious Diseases Society of Sabah, Malaysia

2008-current

  • Member, Australasian Society for Infectious Diseases

 

AWARDS RECOGNITION

2019

  • Royal Australasian College of Physicians AstraZeneca Research Establishment Fellowship

2018     

  • Royal Australasian College of Physicians Research Establishment Fellowship

2017      

  • Charles Darwin University Vice Chancellors Team Award for Excellence in Medical Research (awarded to Menzies Malaria Team)

2015      

  • NHMRC Early Career Research Fellowship

2013      

  • ASID Annual Scientific Meeting Council Scholarship

2012     

  • American Society of Tropical Medicine and Hygiene Young Investigator Award (1st tier mention)

 2012      

  • American Society of Tropical Medicine and Hygiene Travel Award

2012      

  • Australasian Society of Infectious Diseases Best Poster Award

2010      

  • NHMRC Postgraduate Scholarship

 

EDUCATIONAL BACKGROUND

2014: Doctor of Philosophy, Menzies School of Health Research and Charles Darwin University

2010:  Fellowship of the Royal Australasian College of Physicians

2010: Masters of Public Health, University of Melbourne

2007: Diploma of Tropical Medicine and Hygiene (Distinction), University of Liverpool, UK

2001: Bachelor of Medicine, Bachelor of Surgery, University of Melbourne